Euronext Brussels

ONWARD Medical N.V.

HealthcareLEI 9845007A2CC4C8BFSB80Filings at the AFM Nederlands

At a glance

Most recent filing on November 6, 2026 — a grant by Marver D.L. on Oct 1, 2026.

Over the past 12 months: 0 open-market purchases and 9 open-market sales.

We hold 43 visible filings, going back to October 22, 2021.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 43 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings for this company, out of 43. Reading the whole list, and the full filer page behind every line, is part of the subscription. So are the insider score for this company, the price beside each line, the price history with every buy marked on it, any moments when several insiders bought within ninety days, and following this company. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Some of these filings come from the AFM register of board members and supervisory directors (art. 5:48 Wft). The AFM board-member register gives no transaction type; we derive it from the number of shares and the price.

Marver D.L. Board or supervisory board member
369,686 sharesGrant
TradedOct 1, 2026FiledNov 6, 2026
Marver D.L. Board or supervisory board member
€143,386Open-market sale
TradedAug 28, 2026FiledAug 28, 2026
Marver D.L. Board or supervisory board member
€12,138Open-market sale
TradedAug 21, 2026FiledAug 21, 2026
Marver D.L. Board or supervisory board member
€16,264Open-market sale
TradedAug 18, 2026FiledAug 18, 2026
Marver D.L. Board or supervisory board member
€11,528Open-market sale
TradedAug 11, 2026FiledAug 11, 2026

The insider score is a rank of the most recent scored buy, not a forecast. How it is calculated is in the methodology. Source: the Dutch AFM register (MAR art. 19).